Cerebellum GP LLC grew its position in shares of AMETEK, Inc. (NYSE:AME) by 294.7% in the 1st quarter, HoldingsChannel reports. The firm owned 4,200 shares of the technology company’s stock after buying an additional 3,136 shares during the period. AMETEK comprises approximately 0.3% of Cerebellum GP LLC’s portfolio, making the stock its 7th biggest holding. Cerebellum GP LLC’s holdings in AMETEK were worth $348,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also recently bought and sold shares of the company. Dudley & Shanley Inc. increased its holdings in shares of AMETEK by 54.4% during the 1st quarter. Dudley & Shanley Inc. now owns 51,849 shares of the technology company’s stock valued at $4,302,000 after purchasing an additional 18,275 shares in the last quarter. Mn Services Vermogensbeheer B.V. increased its holdings in shares of AMETEK by 1.5% during the 1st quarter. Mn Services Vermogensbeheer B.V. now owns 39,907 shares of the technology company’s stock valued at $3,311,000 after purchasing an additional 600 shares in the last quarter. Gotham Asset Management LLC increased its holdings in shares of AMETEK by 10.8% during the 4th quarter. Gotham Asset Management LLC now owns 172,158 shares of the technology company’s stock valued at $11,655,000 after purchasing an additional 16,829 shares in the last quarter. Mawer Investment Management Ltd. increased its holdings in shares of AMETEK by 1.1% during the 1st quarter. Mawer Investment Management Ltd. now owns 2,983,062 shares of the technology company’s stock valued at $247,507,000 after purchasing an additional 33,839 shares in the last quarter. Finally, Nissay Asset Management Corp Japan ADV increased its holdings in shares of AMETEK by 557.4% during the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 118,115 shares of the technology company’s stock valued at $7,996,000 after purchasing an additional 100,147 shares in the last quarter. 85.92% of the stock is owned by hedge funds and other institutional investors.
In other AMETEK news, Director Steven W. Kohlhagen sold 3,494 shares of AMETEK stock in a transaction on Tuesday, March 19th. The shares were sold at an average price of $81.78, for a total transaction of $285,739.32. Following the sale, the director now owns 55,003 shares of the company’s stock, valued at approximately $4,498,145.34. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Timothy N. Jones sold 5,000 shares of AMETEK stock in a transaction on Thursday, March 28th. The stock was sold at an average price of $82.20, for a total transaction of $411,000.00. Following the sale, the insider now directly owns 37,177 shares in the company, valued at approximately $3,055,949.40. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 73,614 shares of company stock worth $6,314,246. 0.80% of the stock is currently owned by corporate insiders.
Shares of NYSE AME opened at $84.99 on Monday. The firm has a market capitalization of $19.36 billion, a P/E ratio of 25.83, a P/E/G ratio of 2.17 and a beta of 1.21. The company has a quick ratio of 1.27, a current ratio of 1.91 and a debt-to-equity ratio of 0.53. AMETEK, Inc. has a one year low of $63.14 and a one year high of $88.76.
AMETEK (NYSE:AME) last issued its quarterly earnings results on Wednesday, May 1st. The technology company reported $1.00 EPS for the quarter, topping the consensus estimate of $0.97 by $0.03. The company had revenue of $1.29 billion during the quarter, compared to analyst estimates of $1.28 billion. AMETEK had a net margin of 16.14% and a return on equity of 18.56%. The firm’s revenue was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.79 EPS. Equities research analysts expect that AMETEK, Inc. will post 4.08 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Friday, June 14th will be paid a dividend of $0.14 per share. The ex-dividend date is Thursday, June 13th. This represents a $0.56 annualized dividend and a yield of 0.66%. AMETEK’s dividend payout ratio (DPR) is presently 17.02%.
Several brokerages recently commented on AME. DA Davidson boosted their price target on shares of AMETEK to $101.00 and gave the stock a “buy” rating in a report on Thursday, May 2nd. Morgan Stanley set a $95.00 price target on shares of AMETEK and gave the stock a “buy” rating in a report on Friday, May 3rd. KeyCorp boosted their price target on shares of AMETEK from $86.00 to $94.00 and gave the stock an “overweight” rating in a report on Thursday, May 2nd. ValuEngine raised shares of AMETEK from a “hold” rating to a “buy” rating in a report on Wednesday, May 1st. Finally, Vertical Research reissued a “buy” rating on shares of AMETEK in a report on Friday, May 3rd. Fifteen research analysts have rated the stock with a buy rating, The company currently has a consensus rating of “Buy” and a consensus price target of $91.50.
COPYRIGHT VIOLATION WARNING: This story was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another site, it was stolen and reposted in violation of US & international copyright legislation. The original version of this story can be read at https://www.dispatchtribunal.com/2019/06/17/ametek-inc-nyseame-stake-boosted-by-cerebellum-gp-llc.html.
AMETEK Company Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. The company's Electronic Instruments segment offers advanced instruments for the process, aerospace, power, and industrial markets; process control instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.
Read More: The risks of owning bonds
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.